Fractyl Health, Inc. (GUTS)
(Delayed Data from NSDQ)
$7.46 USD
-0.10 (-1.32%)
Updated May 24, 2024 03:59 PM ET
After-Market: $7.43 -0.03 (-0.40%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Fractyl Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | NA | NA | NA |
Cost Of Goods | 0 | 0 | NA | NA | NA |
Gross Profit | 0 | 0 | NA | NA | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 51 | 49 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -51 | -49 | 0 | 0 | 0 |
Non-Operating Income | -26 | 3 | NA | NA | NA |
Interest Expense | 0 | 0 | NA | NA | NA |
Pretax Income | -77 | -46 | NA | NA | NA |
Income Taxes | 0 | 0 | NA | NA | NA |
Minority Interest | 0 | 0 | NA | NA | NA |
Investment Gains/Losses | 0 | 0 | NA | NA | NA |
Other Income/Charges | 0 | 0 | NA | NA | NA |
Income From Cont. Operations | -77 | -46 | NA | NA | NA |
Extras & Discontinued Operations | 0 | 0 | NA | NA | NA |
Net Income (GAAP) | -77 | -46 | NA | NA | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -51 | -49 | 0 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | NA | NA | NA |
Income After Depreciation & Amortization | -51 | -49 | 0 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2.08 | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -32.08 | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | -45.29 | NA | NA | NA | NA |
Fiscal Year end for Fractyl Health, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.03 | 0.01 | NA | NA | 0.01 |
Cost Of Goods | 0.02 | NA | NA | NA | 0.00 |
Gross Profit | 0.01 | NA | NA | NA | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 21.55 | 0.00 | 0.00 | 0.00 | 12.11 |
Income After SG&A, R&D, and Dept/Amort Expenses | -21.54 | 0.00 | 0.00 | 0.00 | -12.11 |
Non-Operating Income | 18.22 | NA | NA | NA | 0.18 |
Interest Expense | 0.00 | NA | NA | NA | 0.00 |
Pretax Income | -3.32 | NA | NA | NA | -11.93 |
Income Taxes | 0.00 | NA | NA | NA | 0.00 |
Minority Interest | 0.00 | NA | NA | NA | 0.00 |
Investment Gains/Losses | 0.00 | NA | NA | NA | 0.00 |
Other Income/Charges | 0.00 | NA | NA | NA | 0.00 |
Income From Cont. Operations | -3.32 | -19.18 | NA | NA | -11.93 |
Extras & Discontinued Operations | 0.00 | 0.00 | NA | NA | 0.00 |
Net Income (GAAP) | -3.32 | -19.18 | NA | NA | -11.93 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 29.74 | 2.10 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.75 | -8.02 | NA | NA | NA |
Diluted Net EPS (GAAP) | -0.17 | -11.18 | NA | NA | NA |